What Happens When You Stop Taking GHK-Cu

GHK-Cu has a plasma half-life of about 30 minutes and a tissue half-life of 24 to 48 hours. After your last dose, the peptide continues working at active sites (skin fibroblasts, wound beds, hair follicles) for another day or two. By day 3 to 5, tissue concentration has fallen below the threshold that drives fibroblast stimulation. By day 7 to 10, GHK-Cu at the tissue level is effectively back to endogenous baseline.

During this window, nothing visible happens. Skin still looks the same. Hair growth that was already in the anagen phase continues. Any wound you were healing continues to heal at the rate set by the last week of treatment. The biology has quieted, but the results of the biology have not yet caught up.

This is the most important thing to understand about stopping GHK-Cu. The peptide is a signal, not a structure. When the signal stops, the structures that the signal built (new collagen, new capillaries, thicker hair shafts) do not dissolve. They persist and gradually turn over on their own natural timelines.

If you are cycling GHK-Cu on a standard 8-weeks-on, 4-weeks-off schedule, this 7 to 10 day washout is the intentional quiet period that lets receptors reset. Chronic uninterrupted dosing can blunt response over time. The pause restores sensitivity. For why this matters, see our GHK-Cu injection frequency guide.

Hair is the fastest-cycling tissue that GHK-Cu supports. The anagen (growth) phase of a human hair follicle lasts 2 to 6 years, but the proliferative signals that GHK-Cu delivers have a much shorter effective window. Once tissue GHK-Cu drops to baseline, the follicle returns to its pre-treatment growth rate within 2 to 4 weeks.

What this looks like in practice:

Weeks 2 to 3: The new hairs that entered anagen during your last 2 weeks of GHK-Cu continue to grow. You do not see thinning. You may see the peak benefit from your cycle because late-stage follicle recruitment is still visible.

Weeks 3 to 4: Hair growth rate slows back to your baseline. If GHK-Cu added 15 to 20 percent to your growth velocity during the cycle, that bonus disappears. Shafts that were thickened by copper-driven matrix activity stop being replaced with thicker shafts.

Weeks 6 to 8: The hair density you gained during the cycle begins to settle. If your baseline was sparse and GHK-Cu added visible volume, some of that volume is lost by this point. Not all. Hairs that were fully cycled into anagen under treatment remain on scalp through their normal lifespan.

The fade is gradual and partial. People who used GHK-Cu topically for hair do not suddenly shed. The improvement softens over 1 to 2 months back toward pre-treatment density, not below it. For the full hair protocol and what to expect on-cycle, see GHK-Cu hair growth.

If you are cycling, restarting within 30 to 60 days of stopping preserves most of the hair gains. Longer breaks mean more regression.

GHK-Cu's wound healing effect is strongest when the peptide is actively present. The molecule signals angiogenesis, recruits fibroblasts, and accelerates collagen deposition at repair sites. When you stop, the acute acceleration stops with it.

Within 4 to 6 weeks of stopping, your baseline wound healing rate returns. If you sustain a cut, abrasion, or surgical wound after that window, it heals on your body's normal timeline, not the accelerated GHK-Cu timeline. A superficial scratch that was closing in 3 days on-cycle now closes in 5 to 7 days, which is normal.

What persists: the scars you healed during the cycle stay healed. Tissue that remodeled under GHK-Cu treatment keeps its improved architecture. Collagen laid down during the cycle is already integrated and continues to mature on the normal 6 to 12 month scar maturation timeline.

What does not persist: the "always faster" repair capacity. You lose the on-demand acceleration. This is the practical reason some users cycle GHK-Cu around known injury windows (post-surgery, planned cosmetic procedures, athletic training blocks where soft tissue stress is high). The peptide provides most benefit during active repair.

For context on how GHK-Cu drives these repair signals at the molecular level, see GHK-Cu benefits. For the safety profile during wound healing use, see GHK-Cu side effects.

Skin is the slowest-reverting tissue after stopping GHK-Cu, and also the most forgiving. Collagen and elastin have a natural turnover of 3 to 6 months in healthy adult dermis. The collagen synthesis stimulation from GHK-Cu peaks at nanomolar concentrations and is independent of fibroblast proliferation, meaning the matrix you laid down during the cycle continues to mature even after dosing stops (Maquart et al., 1988). Changes laid down during a GHK-Cu cycle do not disappear when the peptide stops. They age at the normal rate.

Weeks 6 to 8: Fibroblast activity returns to baseline. New collagen synthesis drops back to whatever your body produces without peptide support. You will not see a difference yet.

Weeks 8 to 12: Daily micro-damage from sun, oxidation, and mechanical stress continues to degrade existing collagen at baseline rates. Without ongoing GHK-Cu support, the net collagen balance shifts slightly negative, the way it would for anyone your age not on the peptide. Fine line softening may gradually diminish. Firmness peaks established during the cycle start to soften.

Months 3 to 6: The collagen you built during the cycle finishes its natural turnover window. By this point, skin has largely returned to the trajectory it would have been on without the peptide. Not worse than baseline. Just on baseline's slope.

What stays: you do not lose the "floor" the cycle built. Skin does not regress below pre-treatment condition. The scaffolding remains; only the active synthesis bonus is gone.

This gradual, partial regression is why many users run GHK-Cu as semi-chronic therapy (5 days on, 2 days off, indefinitely) rather than discrete cycles. For topical users, the same logic applies. See GHK-Cu microneedling for how delivery method affects the longevity of topical results.

Some peptides and most hormones produce a withdrawal state when stopped. Exogenous testosterone suppresses endogenous production, so stopping creates a hypogonadal crash. Stimulants downregulate receptors, so stopping causes fatigue and low mood. Corticosteroids suppress the HPA axis, so tapering is mandatory to avoid adrenal crisis.

GHK-Cu does none of this. It does not suppress endogenous GHK production (your body continues to make its own GHK tripeptide at the normal rate, though endogenous plasma levels naturally decline from ~200 ng/mL at age 20 to ~80 ng/mL by age 60; (Pickart, 2008)). It does not downregulate receptors in a way that creates a performance gap. It does not suppress any hormonal axis. There is no physiological dependence.

What this means practically:

• You can stop GHK-Cu abruptly without tapering.
• You will not experience fatigue, mood changes, or hormonal symptoms.
• You will not shed hair faster than baseline.
• You will not see "rebound aging" or sudden skin deterioration.
• Any transient sensations (injection site calm, skin returning to its normal feel) are subjective, not pharmacological.

The biggest mistake people make when stopping GHK-Cu is expecting withdrawal and interpreting normal life events through that lens. If you notice dry skin 3 weeks after stopping, that is probably because it is winter, not because you stopped GHK-Cu. If hair shedding feels high, check the season (telogen effluvium is cyclic) before blaming discontinuation.

For a broader view of what peptide safety looks like across starting, stopping, and cycling, see the peptide safety guide.

Standard GHK-Cu protocols include planned breaks for two reasons. First, chronic uninterrupted dosing can blunt fibroblast response over time. Second, breaks are simply not costly. The gradual fade means short pauses lose very little.

Common cycle designs:

• 8 weeks on, 4 weeks off: The most common protocol for skin rejuvenation. Peak benefit during the cycle, modest fade during the break, full re-sensitization before restart.
• 12 weeks on, 4 to 8 weeks off: For users targeting deeper collagen remodeling. Longer on-phase drives more structural change, longer off-phase lets tissue settle before the next push.
• 5 days on, 2 days off (weekly): Semi-chronic. Keeps tissue levels high almost continuously with a small weekly washout. Used for indefinite anti-aging maintenance.
• Seasonal cycling: 2 to 3 discrete cycles per year, timed around skin stressors (post-summer UV damage, post-winter dryness) or life events. Cost-efficient, preserves sensitivity.

The biological rationale for breaks: Receptors and signal pathways recover sensitivity during quiet periods. When you restart, tissue response to the peptide is as strong as it was the first time. Skipping breaks often does not harm you, but it reduces the marginal benefit of each additional week of dosing.

What about stopping permanently? Also fine. GHK-Cu is not a commitment. People who try an 8-week cycle, see modest results, and decide it is not worth the cost or injection burden can simply not reorder. The tissue returns to baseline on its own schedule. No follow-up protocol is needed.

For the full injection schedule options and how they map to goals, see GHK-Cu injection frequency.

If you stopped GHK-Cu and decide to restart, the process is simple. There is no loading phase, no ramp-up protocol, no need to taper back in.

If you are off for less than 30 days: Restart at your previous effective dose. Tissue sensitivity is essentially unchanged. You will reach steady state faster than the first time (3 to 5 days instead of 5 to 7) because some downstream adaptations persist.

If you are off for 30 to 90 days: Restart at your previous effective dose. Steady state takes the normal 5 to 7 days. Any regression that occurred during the break will rebuild during the first 2 to 4 weeks of the new cycle.

If you are off for more than 90 days: Effectively a fresh cycle. Restart at whatever dose your protocol specifies (typically 1 to 2 mg daily subcutaneous for skin, or topical per your formulation). Expect the standard 4 to 12 week timeline for visible improvement to apply again.

Reconstitution on restart: If you kept a reconstituted vial refrigerated, check expiration (28 days is the standard window for bacteriostatic water reconstitution). If the vial has been sitting for longer than that, discard and reconstitute a fresh vial. Do not inject peptide from a vial that has shifted from pale blue to dark or cloudy. For the complete reconstitution protocol, see how to reconstitute GHK-Cu and the peptide reconstitution calculator.

Dose adjustments on restart: Most users restart at the dose that worked before. If you had adverse effects previously (injection site irritation, fatigue in the first week) consider dropping to 0.5 mg for the first 3 to 5 days before stepping up. If you had no effects at all, consider increasing by 25 to 50 percent to test for a stronger response.

Cycling is a tool. You will cycle on and off this peptide many times over many years if you use it long-term. Each restart is a normal event, not a reset of the protocol.